在接受pioglitazone治疗的非糖尿病胰岛素耐药患者中,缺血性中风或过渡性缺血性心脏衰竭
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
在PubMed上查看摘要
概括
此摘要是机器生成的。胰岛素耐药性患者中风后,皮奥格利塔并没有增加心力衰竭的风险. 这种药物对心血管有整体益处,在不同基线心力衰竭风险水平上没有增加风险.
科学领域
- 心脏病学
- 神经学
- 内分泌学
背景情况
- 在IRIS试验中,皮奥格利塔降低了胰岛素抵抗患者的心血管事件和糖尿病风险.
- 对于皮奥格利塔可能增加敏感个体心力衰竭 (HF) 风险存在担忧.
研究的目的
- 评估与胰岛素耐药性患者中风后使用皮奥格利塔相关的心力衰竭风险.
- 确定皮奥格利塔对HF风险影响的因素,并评估其心血管益处.
主要方法
- 对IRIS试验的二次分析,重点是没有HF病史的参与者.
- 使用时间到事件方法来判断HF发作,并分析治疗效应.
- 开发了基线HF风险评分,以检查其与pioglitazone作用的相互作用.
主要成果
- 皮奥格利塔和安慰剂组之间5年HF风险没有显著差异 (4. 1%与4. 2%).
- 皮奥格利塔治疗患者的住院HF风险较低,并没有显著增加 (2. 9% vs 2. 3%).
- 皮奥格利塔显著降低了中风,心肌梗塞或住院HF的综合结果 (HR,0. 78;P=0. 007).
结论
- 随着监测和剂量调整,pioglitazone没有增加IRIS参与者的HF风险.
- 在胰岛素抵抗和脑血管疾病患者中,该药物为心血管提供了净益处.
- 基线HF风险没有改变pioglitazone对HF发病率的影响.
相关概念视频
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...